Biotech industry seeks control of its destiny

Biotech industry seeks control of its destiny Human Genome Sciences and a small but determined group of its peers are charting unconventional territory. Their efforts to take over the production, sales and marketing of selected portions of their portfolios signals a potential turning point in the industry. The companies contend that they can and should […]


Singapore's biotech bid

Singapore’s biotech bid Singapore is rolling out the red carpet to foreign scientists and entrepreneurs in an ambitious bid to build up its biotech sector. The government has set aside $2 billion for research in biotech, health care and medical technology until 2005, and pledged $285 million for science scholarships.


Singapore’s biotech bid

Singapore’s biotech bid Singapore is rolling out the red carpet to foreign scientists and entrepreneurs in an ambitious bid to build up its biotech sector. The government has set aside $2 billion for research in biotech, health care and medical technology until 2005, and pledged $285 million for science scholarships.


Big Pharma: Getting Too Big for Its Own Good?

Big Pharma: Getting Too Big for Its Own Good? A study by McKinsey & Co. earlier this year looked at the net present value of products out of research vs. the spending on R&D for the top pharma players over the last decade. It found no correlation between the return on investment and a company’s […]


Woman carries human clone, group says

Woman carries human clone, group says fringe religious movement’s South Korea-based scientific team yesterday said they had implanted a cloned human embryo in a woman, the latest of a string of similar uncomfirmed experiments to emerge from the underground field of human cloning.


Genomics Sector Has Fired More Than 1,500 Staff Since January 2001

Genomics Sector Has Fired More Than 1,500 Staff Since January 2001 The following is a general compilation of the number of employees at genomic tool and tech firms who have lost their jobs as the industry, bookended by slowdowns at biotech and pharma customers, struggles to stay afloat.


Cuba seeks new drug markets

Cuba seeks new drug markets Inside modern towers that are a pride of Fidel Castro, scientists peer through huge microscopes at tiny proteins they hope to tailor to treat such major killers as AIDS, heart disease and cancer.


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog